![]() |
![]() |
Legal status
Patent lapsed (non-payment of fees)
(51) | INT.CL. | C07D 487/04 | (2006.01) |
A61K 31/519 | (2006.01) | ||
A61K 31/5377 | (2006.01) |
(11) | Number of the document | 2096919 |
(13) | Kind of document | T |
(96) | European patent application number | 07862580.3 |
Date of filing the European patent application | 2007-12-05 | |
(97) | Date of publication of the European application | 2009-09-09 |
(45) | Date of publication and mention of the grant of the patent | 2016-03-02 |
(46) | Date of publication of the claims translation | 2016-06-10 |
(86) | Number | PCT/US2007/024985 |
Date | 2007-12-05 |
(87) | Number | WO 2008/070150 |
Date | 2008-06-12 |
(30) | Number | Date | Country code |
873090 P | 2006-12-05 | US |
(72) |
HENTEMANN, Martin, US
WOOD, Jill, US
SCOTT, William, US
MICHELS, Martin, DE
CAMPBELL, Ann-Marie, US
BULLION, Ann-Marie, US
ROWLEY, R. Bruce, US
REDMAN, Aniko, US
|
(73) |
Bayer Intellectual Property GmbH ,
Alfred-Nobel Strasse 50, 40789 Monheim an Rhein,
DE
|
(74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
(54) | Pakeistieji 2,3-dihidroimidazo[1,2-c]chinazolino dariniai, naudingi hiperproliferacinių ligų ir su angiogeneze susijusių ligų gydymui |
SUBSTITUTED 2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLINE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS |
Payment date | Validity (years) | Amount | |
2023-11-23 | 17 | 347.00 EUR |
Patent lapsed (non-payment of fees) | ||
Invalidation date | 2024-12-05 |